Nonetheless, since the majority of breast cancer cases with BRCA1 or BECN1 copy number alteration contain concurrent deletions of both BRCA1 and BECN1, it is difficult to use copy number alterations as a parameter for distinguishing the effects of these two genes in breast cancer. This evidence concerns the gene BECN1 and breast carcinoma.